Histone deacetylase as a target for cancer therapy

被引：0
|
作者：
La Thangue, N
Brown, R
Finn, P
Williams, R
机构：
[1] Univ Glasgow, Div Biochem & Mol Biol, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
[2] CR UK Beatson Labs, Dept Med Oncol, Glasgow G61 1BD, Lanark, Scotland
[3] Prolifix Ltd, Abingdon OX14 4RY, Oxon, England
来源：
BRITISH JOURNAL OF CANCER | 2002年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S9 / S10
页数：2
相关论文
共 50 条
  • [31] Potential use of histone deacetylase inhibitors in cancer therapy
    Golabek, Karolina
    Strzelczyk, Joanna K.
    Wiczkowski, Andrzej
    Michalski, Marek
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2015, 19 (06): : 436 - 440
  • [32] Histone Deacetylase Inhibitors: An Attractive Strategy for Cancer Therapy
    Li, Jiyang
    Li, Guangqiang
    Xu, Wenqing
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (14) : 1858 - 1886
  • [33] Recent advances in histone deacetylase targeted cancer therapy
    Hoshino, Isamu
    Matsubara, Hisahiro
    SURGERY TODAY, 2010, 40 (09) : 809 - 815
  • [34] Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
    Guo, Fengyi
    Wang, Hongjing
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [35] Kinase and Histone Deacetylase Hybrid Inhibitors for Cancer Therapy
    Luan, Yepeng
    Li, Jerry
    Bernatchez, Jean A.
    Li, Rongshi
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (07) : 3171 - 3183
  • [36] Histone deacetylase inhibitors that target tubulin
    Schemies, Joerg
    Sippl, Wolfgang
    Jung, Manfred
    CANCER LETTERS, 2009, 280 (02) : 222 - 232
  • [37] Inhibition of histone deacetylase is a novel target for lung cancer treatment.
    Mukhopadhyay, NK
    Weisberg, E
    Gilchrist, D
    Doerre, G
    Bueno, R
    Sugarbaker, DJ
    Jaklitsch, MT
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1198S - 1198S
  • [38] Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment
    Maria Lehmann
    Michèle J Hoffmann
    Annemarie Koch
    Scott M Ulrich
    Wolfgang A Schulz
    Günter Niegisch
    Journal of Experimental & Clinical Cancer Research, 33
  • [39] Histone deacetylase 2: A potential therapeutic target for cancer and neurodegenerative disorders
    Gediya, Piyush
    Parikh, Palak K.
    Vyas, Vivek K.
    Ghate, Manjunath D.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 216
  • [40] Histone deacetylase 8 is deregulated in urothelial cancer but not a target for efficient treatment
    Lehmann, Maria
    Hoffmann, Michele J.
    Koch, Annemarie
    Ulrich, Scott M.
    Schulz, Wolfgang A.
    Niegisch, Guenter
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2014, 33
12345